Lonza snaps up Cambrex 'bio businesses'
Contract manufacturer Lonza has completed its acquisition of two Cambrex subsidiaries, research bioproducts and microbial biopharmaceutical, in a move that is fuelled by its strategic move into biopharmaceuticals.